[Advances in measurements and standardization of plasma phosphorylated tau217 as a biomarker for Alzheimer's disease].

With the approval of targeted drugs for modification therapy of Alzheimer's disease, the role of blood markers in the diagnosis and treatment of Alzheimer's disease is becoming more and more important. The economical and easily accessible plasma phos…

Preview only. Read the full abstract at the source